Tissue scaffolds functionalized with therapeutic elastin-like biopolymer particles

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Drug Delivery Systems

Background:

• Tissue engineering scaffolds support cell activity for tissue regeneration.
• Sustained release of growth factors from scaffolds can improve therapeutic outcomes, particularly in wound healing.
• Elastin-like peptides (ELPs) offer a versatile platform for drug delivery.

Purpose of the Study:

• To incorporate KGF-ELP therapeutic particles into alloderm scaffolds.
• To evaluate the sustained release and bioactivity of KGF-ELPs from the scaffold.
• To assess the efficacy of KGF-ELP functionalized scaffolds in promoting wound healing in vivo.

Main Methods:

• Fusion of elastin-like peptides (ELPs) with keratinocyte growth factor (KGF) to create therapeutic particles.
• Incorporation of KGF-ELP particles into an alloderm tissue scaffold.
• In vitro cell proliferation assays to confirm bioactivity.
• In vivo mouse pouch model to evaluate cellular infiltration and vascularization.

Main Results:

• Sustained release of KGF-ELPs from the alloderm scaffold was successfully achieved.
• In vitro assays confirmed the bioactivity of the released KGF-ELP particles.
• In vivo studies showed increased cellular infiltration and vascularization in scaffolds functionalized with KGF-ELPs compared to controls.

Conclusions:

• The developed KGF-ELP functionalized alloderm scaffolds provide sustained release of bioactive growth factors.
• These scaffolds show significant potential for enhancing wound healing by promoting cellular infiltration and vascularization.
• This approach represents a promising strategy in tissue engineering for regenerative therapies.